article thumbnail

The Wait is Over. Or Is It? DEA’s Proposed Rules Around Telemedicine Prescribing: Initial Impressions and Key Takeaways

Health Law Advisor

The proposed rules are more restrictive than the DEA emergency waivers under which providers conducted telemedicine prescribing for the last three years, but are less restrictive in comparison to the pre-PHE regulations applicable to telemedicine prescribing of controlled substances under the federal Controlled Substances Act (“CSA”).

article thumbnail

Recent Developments in Telehealth Enforcement

Healthcare Law Blog

Now, almost three years later, governmental entities have focused their attention on telehealth services and the potential for fraud and abuse. Although the PHE and its telehealth flexibilities currently remain in effect, the DOJ has started to investigate allegations of fraud and violations of the Controlled Substances Act.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

States and Feds Signal Big Changes to Telehealth Prescribing

Health Law Advisor

Last July, the Department of Health and Human Services’ Office of Inspector General (“OIG”) published a Special Fraud Alert detailing high-risk activities conducted by telehealth providers and has, to date, indicted 31 telehealth providers alleging various health care fraud and abuse schemes. 18 U.S.C. § Under 21 U.S.C. §

article thumbnail

Health Provider News

Hall Render

for physician referral scheme In Los Angeles, hospital CEO pay could be capped Kaiser Permanente ratings affirmed amid healthy financial profile Nurses vote ‘no confidence’ in California hospital administration, board Nursing facility, management company settle physician kickback allegations for $3.8M